Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Subgroup variations in bone mineral density response to zoledronic acid after hip fracture.
Magaziner JS, Orwig DL, Lyles KW, Nordsletten L, Boonen S, Adachi JD, Recknor C, Colón-Emeric CS, Mesenbrink P, Bucci-Rechtweg C, Su G, Johnson R, Pieper CF. Magaziner JS, et al. Among authors: adachi jd. J Bone Miner Res. 2014 Dec;29(12):2545-51. doi: 10.1002/jbmr.2283. J Bone Miner Res. 2014. PMID: 24839241 Free PMC article. Clinical Trial.
Zoledronic acid and clinical fractures and mortality after hip fracture.
Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S; HORIZON Recurrent Fracture Trial. Lyles KW, et al. Among authors: adachi jd. N Engl J Med. 2007 Nov 1;357(18):1799-809. doi: 10.1056/NEJMoa074941. Epub 2007 Sep 17. N Engl J Med. 2007. PMID: 17878149 Free PMC article. Clinical Trial.
Geographic variation of bone mineral density and selected risk factors for prediction of incident fracture among Canadians 50 and older.
Langsetmo L, Hanley DA, Kreiger N, Jamal SA, Prior J, Adachi JD, Davison KS, Kovacs C, Anastassiades T, Tenenhouse A, Goltzman D; CaMos Research Group. Langsetmo L, et al. Among authors: adachi jd. Bone. 2008 Oct;43(4):672-8. doi: 10.1016/j.bone.2008.06.009. Epub 2008 Jul 1. Bone. 2008. PMID: 18640295 Free PMC article.
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate.
Miller PD, Delmas PD, Lindsay R, Watts NB, Luckey M, Adachi J, Saag K, Greenspan SL, Seeman E, Boonen S, Meeves S, Lang TF, Bilezikian JP; Open-label Study to Determine How Prior Therapy with Alendronate or Risedronate in Postmenopausal Women with Osteoporosis Influences the Clinical Effectiveness of Teriparatide Investigators. Miller PD, et al. J Clin Endocrinol Metab. 2008 Oct;93(10):3785-93. doi: 10.1210/jc.2008-0353. Epub 2008 Aug 5. J Clin Endocrinol Metab. 2008. PMID: 18682511 Free PMC article. Clinical Trial.
Association between change in BMD and fragility fracture in women and men.
Berger C, Langsetmo L, Joseph L, Hanley DA, Davison KS, Josse RG, Prior JC, Kreiger N, Tenenhouse A, Goltzman D; CaMos Research Group. Berger C, et al. J Bone Miner Res. 2009 Feb;24(2):361-70. doi: 10.1359/jbmr.081004. J Bone Miner Res. 2009. PMID: 18847328 Free PMC article.
Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture.
Eriksen EF, Lyles KW, Colón-Emeric CS, Pieper CF, Magaziner JS, Adachi JD, Hyldstrup L, Recknor C, Nordsletten L, Lavecchia C, Hu H, Boonen S, Mesenbrink P. Eriksen EF, et al. Among authors: adachi jd. J Bone Miner Res. 2009 Jul;24(7):1308-13. doi: 10.1359/jbmr.090209. J Bone Miner Res. 2009. PMID: 19257818 Free PMC article. Clinical Trial.
524 results